Efficacy and tolerability of high dose "ethinylestradiol" in post-menopausal advanced breast cancer patients heavily pre-treated with endocrine agents

BACKGROUND: High dose estrogens (HDEs) were frequently used as endocrine agents prior to the introduction of tamoxifen which carries fewer side effects. Due to the development of resistance to available endocrine agents in almost all women with metastatic breast cancer, interest has renewed in the u...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Amit, Robertson, John FR, Cheung, KL
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533829/
https://www.ncbi.nlm.nih.gov/pubmed/16834778
http://dx.doi.org/10.1186/1477-7819-4-44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533829/
https://www.ncbi.nlm.nih.gov/pubmed/16834778
http://dx.doi.org/10.1186/1477-7819-4-44

Ejemplares similares